Gary Fink
Rheumatology · Summerville, SCNPI 1699873885
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.6%), ownership interests and royalties or licence payments — rather than concentrated in one kind of arrangement. American Rheumatology Network, LLC accounts for 98.7% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $1,025,084, more than ten times the $1,717 reported in 2019. Among rheumatology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 403 payments — averaging $7091.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- American Rheumatology Network, LLC$2.8M
- AbbVie$32K
- Johnson & Johnson$1K
- Amgen$894
- UCB, Inc.$452
- E.r. Squibb & Sons, L.L.C.$425
- plus $3K from 20 others
Across 6 payments — averaging $676,552 each. An ownership or investment interest held by the physician or an immediate family member.
- American Rheumatology Network, LLC$4.1M
What the payments were for
- Royalty or licence$624,22122%
- Consulting fees$1,445,14751%
- Speaking & faculty fees$2,5000%
- Grants$28,8341%
- Travel & lodging$6320%
- Food & beverage$7,4030%
- Education$4770%
- Ownership interest$748,61126%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| American Rheumatology Network, LLC | 12 | $2,819,607 |
| AbbVie | 58 | $32,148 |
| Johnson & Johnson(2 entities) | 85 | $1,381 |
| Amgen(2 entities) | 50 | $894 |
| UCB, Inc. | 29 | $452 |
| E.r. Squibb & Sons, L.L.C. | 25 | $425 |
| Novartis | 25 | $380 |
| Octapharma USA, Inc. | 2 | $331 |
| GSK | 19 | $315 |
| Pfizer | 26 | $310 |
| Janssen Scientific Affairs, LLC | 3 | $296 |
| AstraZeneca(2 entities) | 11 | $184 |
| Aurinia Pharma U.S., Inc. | 6 | $146 |
| Boehringer Ingelheim | 9 | $130 |
| Radius Health, Inc. | 6 | $128 |
| Genentech USA, Inc. | 6 | $125 |
| Lilly USA, LLC | 7 | $109 |
| Biogen | 1 | $103 |
| Merck | 6 | $79 |
| Organon | 5 | $77 |
| Hikma Pharmaceuticals USA | 4 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $48 |
| Ultragenyx Pharmaceutical Inc. | 2 | $31 |
| Boston Scientific | 1 | $30 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Sanofi | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$31,334
- OCTAGAM IMMUNE GLOBULIN (HUMAN)$273
- Tremfya$115
- SIMPONI ARIA$115
- STELARA$115
- TYSABRI$103
How this compares
$2,857,826 in reported general payments places this provider in the 95th percentile of 123 rheumatology providers in South Carolina.
Other rheumatology in Summerville
- Colin EdgertonSummerville$3.5M
- Gregory NiemerSummerville$2.9M
- Clarence LegertonSummerville$2.9M
- Jennifer MurphySummerville$2.8M
- William EdwardsSummerville$1.3M
- Nicholas HoldgateSummerville$23K
- Bradley CollinsSummerville$6K
- Durga AdhikariSummerville$5K
- Alan BrownGreenville$947K
- Douglas ConawayMyrtle Beach$500K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.